Back to All Events

2026 Best of ASCO® Los Angeles


  • Le Méridien Pasadena Arcadia 130 West Huntington Drive Arcadia, CA, 91007 United States (map)

In-Person Access Only | 8.25 CME Credits & MOC Points

Please read:All programs remain free. Registrations will require a credit card as a cancellation hold. A fee of $99 will only be incurred in the event of a no-show or cancellation within 5 days without written confirmation to the Total Health Program Team. Industry representatives—defined as any individual who is employed by, contracted with, owns, or represents a drug, device, diagnostic, or other healthcare-related commercial entity, regardless of clinical credentials or licensure—are not permitted to attend Total Health events as general attendees. Members of industry must contact exhibits@totalhealthoncology.com

Total Health's 2026 Best of ASCO® Los Angeles Conference is an officially licensed Best of ASCO® meeting. This Post ASCO® Review showcases abstracts from highly rated presentations, allowing attendees to engage with the latest research and strategies in oncology education. This accredited meeting will be hosted as an in-person conference only with on-demand access for registered attendees.

 

Conference Agenda
Saturday, June 13, 2026

8:00 AM
Coffee and Exhibits

8:30 AM
Program Chair Welcome‍ ‍
Nataliya Mar, MD | Chao Comprehensive Cancer Center - University of California Irvine

8:40 AM
Colorectal Cancer
Nicholas Hornstein, MD | Northwell Health

9:10 AM
Head and Neck Cancer
Ezra Cohen, MD | University of San Diego

9:40 AM
Breakfast and Exhibits

9:55 AM
Non-CME Breakfast - Regeneron - Immunotherapy In Practice: A Compelling Case-Based Discussion Examining Actual Patients with NSCLC

Shiven Patel, MD | Huntsman Cancer Institute, University of Utah

10:40 AM
Prostate Cancer
Nataliya Mar, MD | Chao Comprehensive Cancer Center - University of California Irvine - Program Chair

11:10 AM
Non-Prostate Cancer

Bradley McGregor, MD | Dana Farber Cancer Institute‍ ‍

11:40 AM
Lunch and Exhibits

11:55 AM
Non-CME Lunch - Incyte - Redefining the Treatment of Squamos Cell Carcinoma of the Anal Canal (SCAC) | ZYNYZ® (retifanlimab-dlwr) The First and Only FDA-Approved PD-1 Inhibitor for Adults with Inoperable Locally Recurrent or Metastatic SCAC

Jennifer Valerin, MD | University of California at Irvine

12:40 PM
Housekeeping and Survey

12:50 PM
Leukemia

Ann Mohrbacher, MD | USC Keck School of Medicine

1:20 PM
Lymphoma
Swetha Thiruvengadam, MD | City of Hope

1:50 PM
Multiple Myeloma
Rebecca Silbermann, MD | Oregon Health & Science University

2:20 PM
Melanoma

Vincent Ma, MD | University of Wisconsin, School of Medicine and Public Health

2:50 PM
Gynecological Oncology
Ritu Salani, MD | UCLA Health

3:30 PM
NETWORKING RECEPTION

Sunday, June 14, 2026

8:00 AM
Coffee and Exhibits

8:30 AM
Program Chair Welcome
Zev Wainberg, MD | UCLA Health - Program Chair


8:40 AM
Small Cell Lung Cancer

J.Marie Suga, MD, MPH | Kaiser Permanente

9:10 AM
Non-Small Cell Lung Cancer
Shiven Patel, MD | University of Utah

9:40 AM
Breakfast and Exhibits

9:55 AM
Non-CME Breakfast - Pfizer Breast - Treatment Considerations for Patients with HR+/HER2- mBC
Linnea Chap, MD | Beverly Hills Cancer
Center

10:40 AM
Non-Colorectal Cancer
Zev Wainberg, MD | UCLA Health - Program Chair

11:10 AM
Sarcomas and Rare Cancers
Leo Mascarenhas, MD, MS | Cedars-Sinai Medical Center

11:40 AM
Neuroedocrine Tumors
Jaydira Del Rivero, MD | Bethesda, MD

12:00 PM
Lunch and Exhibits

12:15 PM
Non-CME Lunch - AbbVie - Diving Deep into 1L CLL with BCL2 Inhibitor-Based Fixed-Duration Regimens

Shawn Streeter, PharmD | AbbVie

1:00 PM
Survivorship
Neha Goyal, PhD | UCSF

1:30 PM
Early-Stage Breast Cancer
Norah Lynn Henry, MD | University of Michigan

2:00 PM
Metastatic Breast Cancer
Kamel Abou Hussein, MD | Cooper University

2:30 PM
Adjourn

Agenda Subject To Change. All times are PST.

 
    • Integrate new evidence into everyday clinical practice, thereby improving the quality of care being delivered to patients living with and beyond cancer.

    • Implement practice changes in a variety of treatment options for solid tumors, including lung, breast, melanoma, colorectal, non-colorectal GI, and GU cancers

    • Stimulate innovative strategies for new and additional research related to treatment and prevention

    • Recognize the implications for practice change in both the academic and community practice settings

  • In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Nurses (ANCC) Credit Designation

    Amedco LLC designates this activity for a maximum of 8.25 ANCC contact hours.

    Physicians (ACCME) Credit Designation

    Amedco LLC designates this live activity for a maximum of 8.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Pharmacists and Pharmacy Technicians (ACPE) Credit Designation

    Amedco LLC designates this activity for a maximum of 8.25 knowledge-based CPE contact hours.

    NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of your participation in the activity to meet the deadline for submission to CPE Monitor.

    American Board of Internal Medicine (ABIM) MOC Credit

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 8.25 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. You must request your certificate within 30 days of the activity to meet the deadline for submission to PARS.

    • Free registration for all healthcare providers

    • Expert sessions that present the most clinically relevant data, research, and clinical strategies

    • Enduring video content for watching at your leisure

    • Real-time discussion and debate

    • Networking with peers, colleagues, and medical professionals

    • Access to the latest industry information and resources

    • Catered meals through-out the program

 
Previous
Previous
June 13

2026 Best of ASCO® Austin

Next
Next
June 13

2026 Best of ASCO® Puerto Rico